Back
EPAM Systems Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
23
EPAM
EPAM Systems
Last Price:
$175.82
Seasonality Move:
12.77%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.45
Seasonality Move:
5.74%
Sell
23
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
-
The current EPAM Systems [EPAM] share price is $180.63. The Score for EPAM is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.78. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $180.63The current trend is moderately bullish and EPAM is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
EPAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 12.1 | Buy |
Relative Strength Index (14 RSI): | 58.84 | Buy |
Chaikin Money Flow: | -717678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (153.56 - 182.24) | Buy |
Bollinger Bands (100): | (161.79 - 239.25) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 44.9 | Sell |
Chaikin Money Flow: | 1310696 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.04 - 19.02) | Sell |
Bollinger Bands (100): | (19.37 - 29.83) | Sell |
EPAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 184.18 | Sell |
20-day SMA: | 172.33 | Buy |
50-day SMA: | 166.66 | Buy |
200-day SMA: | 206.63 | Sell |
8-day EMA: | 181.76 | Sell |
20-day EMA: | 172.85 | Buy |
50-day EMA: | 140.62 | Buy |
200-day EMA: | 60.01 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.4 | Buy |
20-day SMA: | 18.11 | Sell |
50-day SMA: | 20.11 | Sell |
200-day SMA: | 28.63 | Sell |
8-day EMA: | 17.67 | Buy |
20-day EMA: | 18.1 | Sell |
50-day EMA: | 20.2 | Sell |
200-day EMA: | 28.78 | Sell |
EPAM Systems Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.04 per share, and an increase next year of $1.27 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
EPAM Systems Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |